method
check
antivir
activ
mononuclear
phagocyt
macrophag
describ
two
type
antivir
activ
defin
intrins
antivir
activ
determin
outcom
viru
replic
macrophag
per
se
wherea
extrins
antivir
activ
refer
abil
reduc
viru
product
surround
cell
normal
permiss
interpret
data
discuss
cell
mononuclear
phagocyt
system
compris
wide
distribut
cell
system
includ
immatur
cell
bone
marrow
circul
monocyt
tissu
macrophag
macrophag
strateg
place
portal
entri
eg
alveolar
macrophag
lung
wide
distribut
organ
close
contact
circul
blood
eg
kupffer
cell
liver
thu
ideal
posit
encount
virus
earli
infecti
process
mim
two
type
macrophag
antivir
activ
defin
vitro
morahan
et
al
mors
et
al
name
intrins
extrins
intrins
interact
refer
outcom
viru
replic
macrophag
per
se
macrophag
may
possess
variou
degre
intrins
suscept
permiss
resist
nonpermiss
viru
replic
activ
studi
mani
differ
virus
herp
simplex
viru
leari
et
al
et
al
sethi
et
al
influenza
viru
robert
et
al
human
immunodefici
viru
gendelman
et
al
meltzer
et
al
vaccinia
viru
keller
et
al
mous
hepat
viru
keller
et
al
intrins
resist
easili
assay
infect
macrophag
cultur
given
viru
usual
multipl
one
infecti
viru
particl
per
macrophag
determin
viru
growth
presenc
viral
antigen
infecti
center
extrins
antivir
activ
macrophag
defin
abil
inactiv
extracellular
viru
reduc
product
surround
cell
normal
permiss
f
kellerjourn
lrnmunolog
method
describ
number
unrel
virus
includingherp
simplex
viru
wildi
et
al
vaccinia
viru
keller
et
al
mous
hepat
viru
keller
et
al
vesicular
stomat
viru
leblanc
et
al
macrophag
intrins
antivir
assay
describ
involv
kupffer
cell
kc
isol
murin
liver
infect
mous
hepat
viru
member
coronaviru
famili
induc
diseas
whose
sever
host
depend
levyleblond
et
al
mice
aj
strain
fulli
resist
mice
balbc
strain
highli
suscept
viru
suffer
fulmin
hepat
macrophag
extrins
antivir
assay
describ
involv
ad
kupffer
cell
kc
suscept
cell
previous
infect
vaccinia
viru
subsequ
assay
viru
produc
kc
permiss
vaccinia
viru
two
method
use
screen
macrophag
differ
sourc
antivir
activ
studi
macrophag
activ
differ
virus
assum
reader
familiar
basic
techniqu
virolog
assay
viru
studi
field
reagent
materi
steril
step
done
steril
condit
assay
describ
kc
isol
accord
method
previous
describ
keller
kc
cultur
dulbecco
modifi
eagl
medium
eurobio
pari
franc
supplement
heatinactiv
fetal
calf
serum
antibiot
human
kb
transform
cell
line
maintain
monolay
eagl
basal
medium
eurobio
pari
franc
supplement
fetal
calf
serum
copenhagen
strain
vaccinia
viru
use
viru
titer
determin
plaqu
format
cell
express
plaqueform
unit
pfu
mous
hepat
viru
cultur
titrat
cell
tissu
cultur
plate
use
costar
linbro
assay
kc
place
plate
viabl
cellswel
h
es
cherichia
coli
phenol
extract
lyposaccharid
difco
laboratori
detroit
mi
use
activ
kc
respons
explant
kc
lp
studi
use
two
parallel
experiment
group
cultur
untreat
cultur
cultur
treat
h
grade
dose
lp
h
treatment
medium
remov
cell
use
assay
control
kc
receiv
complet
medium
without
lp
day
assay
kc
cultur
wash
serumfre
medium
infect
multipl
pfu
per
cell
adsorpt
h
unadsorb
viru
remov
wash
fresh
medium
ad
well
differ
time
postinfect
plate
frozen
assay
viru
content
group
kc
least
replic
well
use
least
two
well
uninfect
per
group
serv
control
target
cell
use
measur
extrins
antiviralact
mononuclear
phagocyt
must
suscept
viru
studi
assay
describ
target
cell
use
assay
suscept
kb
cell
seed
monolay
cm
tissu
cultur
flask
falcon
divis
becton
dickinson
h
start
assay
isol
kc
cultur
tissu
cultur
plate
linbro
flow
laboratori
dulbeccohep
medium
ph
contain
newborn
calfserum
cell
cellswel
use
h
incub
necessari
kc
could
plate
tissu
cultur
plate
costar
medium
cellswel
reaction
explant
kc
lp
studi
use
two
parallel
experiment
group
cultur
name
untreat
cultur
cultur
treat
h
differ
dose
lp
h
treatment
medium
remov
cell
use
assay
control
kc
periton
cell
receiv
complet
medium
without
lp
day
assay
vaccinia
viru
adsorb
kb
cell
monolay
cm
tissu
cultur
flask
approxim
plaqueform
unit
per
cell
h
remov
unadsorb
viru
wash
cell
detach
trypsin
ad
well
coat
h
old
cultur
kc
activ
h
treatment
lp
cocultur
incub
h
air
co
plate
frozen
check
use
viru
plaqu
assay
cell
monolay
effector
target
cell
ratio
use
assay
group
least
replic
well
includ
least
three
well
without
kc
use
control
lpsactiv
kc
resist
suscept
strain
mice
check
intrins
antivir
activ
order
determin
whether
parallel
strain
relat
suscept
resist
kc
suscept
anim
fig
kc
cultur
provid
fruit
model
studi
certain
modal
inborn
resist
mice
result
confirm
genet
determin
sensit
mice
infect
reflect
hepat
macrophag
increas
resist
viru
replic
cell
activ
lp
effici
antivir
state
induc
lp
correspond
resist
suscept
shown
strain
vivo
experi
conduct
elev
concentr
lp
sinc
kc
less
sensit
lp
comparison
periton
macrophag
inhibit
viru
multipl
dose
depend
highest
effect
obtain
izgml
higher
dose
lp
inhibit
could
longer
observ
therebi
suggest
rel
high
concentr
lp
use
experi
influenc
viabil
cell
sinc
permit
replic
viru
determin
antivir
activ
new
viru
detail
need
optim
viru
input
multipl
infect
viru
import
found
low
moi
give
optim
result
nonstimul
periton
exud
cell
pec
kc
freshli
isol
normal
rat
exert
slight
antivir
effect
vaccinia
multipl
target
cell
fig
effect
observ
throughout
experi
vaccinia
viru
replic
consider
inhibit
infect
cell
cocultur
lpsstimul
pec
enhanc
inhibitori
effect
lp
treatment
kc
absenc
detect
activ
kc
lp
may
due
damag
membran
collagenas
treatment
isol
procedur
therefor
cultur
cell
h
prior
use
order
allow
reexpress
surfac
receptor
condit
antivir
activ
kc
remark
enhanc
lp
treatment
mark
inhibit
viru
replic
confirm
fig
kc
periton
exud
cell
pec
isol
normal
anim
cultur
medium
without
activ
substanc
slight
signific
antivir
activ
experi
phenomenon
gener
explain
activ
state
cell
caus
vivo
microenviron
addit
assay
macrophag
extrins
antivir
activ
measur
effect
viru
replic
one
measur
direct
cytotox
virusinfect
cell
leblanc
moranhan
et
al
necessari
rule
involv
natur
killer
cell
nk
macrophag
repres
import
earli
barrier
establish
viru
infect
abil
exert
intrins
extrins
restrict
viru
replic
two
antivir
mechan
intrins
restrict
probabl
import
initi
infect
sinc
repres
constitut
part
defens
system
immedi
avail
extrins
restrict
hand
may
becom
import
cours
infect
sinc
properti
activ
macrophag
mogensen
intrins
interact
refer
outcom
viru
replic
macrophag
per
se
nonpermiss
situat
either
viru
intern
macrophag
endocytosi
destroy
lysomon
enzym
macrophag
infect
viru
viru
replic
abort
keller
et
al
permiss
situat
hand
viru
replic
product
macrophag
viral
particl
releas
infect
may
thu
proceed
moreov
infect
monocyt
circul
may
serv
vehicl
dissemin
throughout
bodi
mim
number
experiment
variabl
may
influenc
outcom
virusmacrophag
interact
sourc
macrophag
ie
alveolar
periton
etc
olafsson
et
al
use
nonspecif
irrit
morahan
et
al
differenti
monocyt
turpin
et
al
mechan
render
macrophag
restrict
cell
type
number
virus
still
unknown
wu
et
al
applic
new
molecular
techniqu
better
definit
molecular
basi
nonpermiss
macrophag
virus
quickli
emerg
extrins
interact
refer
macrophag
influenc
extracellular
viru
viru
replic
surround
cell
morahan
et
al
extrins
antivir
activ
gener
express
normal
unstimul
macrophag
sever
mechan
demonstr
involv
limit
divers
viru
group
morahan
et
al
mechan
given
interact
appear
depend
particular
macrophag
particular
strategi
replic
viru
wildi
et
al
stohlman
et
al
current
known
whether
intrins
extrins
restrict
virus
macrophag
relat
phenomena
fact
given
macrophag
popul
may
show
high
intrins
antivir
activ
extrins
antivir
activ
may
indic
case
instanc
resid
macrophag
gener
intrins
resist
herp
simplex
viru
replic
thioglycol
induc
macrophag
wherea
latter
show
high
extrins
restrict
morahan
futur
work
assess
basic
natur
antivir
action
macrophag
possibl
posit
modul
antivir
properti
